Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Nitrogen Binding Agent [EPC]
Sus Scrofa Ileum is a specialized biological agent classified as a Nitrogen Binding Agent [EPC] and Allergenic Extract. It is utilized in metabolic support and allergy diagnostics, often derived from porcine small intestine tissue.
Name
Sus Scrofa Ileum
Raw Name
SUS SCROFA ILEUM
Category
Nitrogen Binding Agent [EPC]
Drug Count
6
Variant Count
6
Last Verified
February 17, 2026
About Sus Scrofa Ileum
Sus Scrofa Ileum is a specialized biological agent classified as a Nitrogen Binding Agent [EPC] and Allergenic Extract. It is utilized in metabolic support and allergy diagnostics, often derived from porcine small intestine tissue.
Detailed information about Sus Scrofa Ileum
References used for this content
This page is for informational purposes only and does not replace medical advice. Consult a qualified healthcare professional before using any medication containing Sus Scrofa Ileum.
Sus Scrofa Ileum is a complex biological substance derived from the ileum (the final section of the small intestine) of the domestic pig (Sus scrofa). In the landscape of modern pharmacology, it occupies a unique niche, primarily classified by the FDA as a Nitrogen Binding Agent [EPC]. This classification indicates its primary therapeutic utility involves the sequestration or metabolic processing of nitrogenous waste products within the human body. Furthermore, it is recognized under several other Established Pharmacologic Classes (EPC), including Non-Standardized Food Allergenic Extract [EPC], Standardized Chemical Allergen [EPC], and in certain formulations, it is associated with Vitamin C [EPC] and Tetracycline-class Antimicrobial [EPC] profiles.
Historically, porcine-derived glandular extracts have been used in various medical traditions, but the modern clinical application of Sus Scrofa Ileum is more precise. As a nitrogen-binding agent, it is often explored in the context of metabolic disorders where the body struggles to process ammonia or other nitrogenous byproducts. According to the FDA’s National Drug Code (NDC) directory, Sus Scrofa Ileum is frequently found in homeopathic preparations and specialized allergenic extracts. While it may not be a first-line therapy for acute conditions, it plays a significant role in integrative protocols and diagnostic allergy testing. It is important to note that many products containing Sus Scrofa Ileum are marketed under the Homeopathic Pharmacopoeia of the United States (HPUS) standards, which differ from the rigorous clinical trial requirements of conventional synthetic pharmaceuticals.
The mechanism of action for Sus Scrofa Ileum is multifaceted, reflecting its diverse EPC classifications. As a Nitrogen Binding Agent, its primary activity is characterized as Ammonium Ion Binding Activity [MoA]. At the molecular level, the extract contains specific proteins and enzymatic precursors that facilitate the conversion or binding of free ammonia (NH3) and ammonium ions (NH4+) in the gastrointestinal tract or systemic circulation. By binding these ions, the substance helps reduce the toxic burden on the liver and kidneys, particularly in patients with compromised urea cycle function or chronic hepatic insufficiency.
In its role as an Allergenic Extract, Sus Scrofa Ileum works by introducing specific porcine proteins to the immune system. This is used either in diagnostic skin prick testing to identify hypersensitivity or in immunotherapy protocols designed to desensitize the patient’s immune response to porcine-derived foods or environmental allergens. The presence of Vitamin C in certain Sus Scrofa Ileum formulations acts as a redox stabilizer, protecting the biological integrity of the ileal proteins and supporting collagen synthesis in the host. The Tetracycline-class association, though less common in pure extracts, suggests that certain formulations may incorporate antimicrobial properties to modulate the gut microbiome, which is a significant source of endogenous nitrogen production.
Understanding the pharmacokinetics of a biological extract like Sus Scrofa Ileum requires a different approach than synthetic small molecules. Because it is a complex mixture of proteins, lipids, and enzymes, its 'absorption' is often a process of enzymatic degradation and peptide transport.
Sus Scrofa Ileum is utilized in several distinct clinical scenarios:
Sus Scrofa Ileum is available in several specialized delivery formats:
> Important: Only your healthcare provider can determine if Sus Scrofa Ileum is right for your specific condition. The efficacy and safety of biological extracts can vary significantly between manufacturers.
The dosage of Sus Scrofa Ileum is not standardized across all products due to its nature as a biological extract. However, clinical guidelines generally suggest the following ranges for adults:
Sus Scrofa Ileum has not been extensively studied in pediatric populations for general nitrogen binding.
In patients with chronic kidney disease (CKD), the elimination of nitrogenous waste is already compromised. While Sus Scrofa Ileum acts as a nitrogen binder, excessive protein-based extracts could theoretically increase the renal load. Patients with a GFR (Glomerular Filtration Rate) below 30 mL/min should use this agent with extreme caution and frequent monitoring of BUN (Blood Urea Nitrogen) levels.
Sus Scrofa Ileum is often used because of hepatic impairment. However, in cases of acute liver failure, the body’s ability to process any porcine-derived proteins may be diminished. Dose adjustments are typically not required for mild-to-moderate cirrhosis, but close monitoring for hepatic encephalopathy symptoms is mandatory.
Geriatric patients often have reduced gastric acid production (hypochlorhydria), which may alter the digestion and absorption of Sus Scrofa Ileum capsules. A lower starting dose is recommended to assess gastrointestinal tolerance.
If you miss a dose, take it as soon as you remember. However, if it is nearly time for your next scheduled dose, skip the missed dose and resume your regular schedule. Do not 'double up' on doses to catch up, as this can lead to gastrointestinal distress or an imbalance in nitrogen metabolism.
Signs of an overdose of Sus Scrofa Ileum may include:
In the event of a suspected overdose, contact your local poison control center or seek emergency medical attention immediately. Treatment is generally supportive, focusing on hydration and electrolyte stabilization.
> Important: Follow your healthcare provider's dosing instructions exactly. Do not adjust your dose or stop taking this medication without medical guidance, especially if being used for metabolic management.
Because Sus Scrofa Ileum is a biological extract, most common side effects are localized to the gastrointestinal tract. These may include:
These effects are typically transient and resolve as the body adapts to the supplement, usually within 7 to 10 days of consistent use.
> Warning: Stop taking Sus Scrofa Ileum and call your doctor immediately if you experience any of the following serious symptoms:
Prolonged use of Sus Scrofa Ileum (longer than 6 months) requires clinical oversight. Potential long-term effects include:
As of 2026, there are no FDA-mandated Black Box Warnings for Sus Scrofa Ileum when used as a nitrogen-binding agent or allergenic extract. However, healthcare providers are cautioned that porcine-derived products carry an inherent risk for patients with known alpha-gal syndrome or severe pork allergies.
Report any unusual symptoms or persistent side effects to your healthcare provider. You may also report side effects to the FDA at 1-800-FDA-1088.
Sus Scrofa Ileum is a biological product and must be handled with the same caution as other animal-derived therapies. It is not a substitute for standard medical treatments for liver or kidney failure but rather an adjunctive support. Patients must ensure they are using a pharmaceutical-grade or HPUS-compliant source to minimize the risk of contaminants.
No FDA black box warnings for Sus Scrofa Ileum. However, clinicians should remain vigilant regarding the potential for severe hypersensitivity in sensitized individuals.
The most significant risk associated with Sus Scrofa Ileum is a Type I hypersensitivity reaction. Because the drug is derived from Sus scrofa (pig), any patient with a known allergy to pork, gelatin, or other porcine products must avoid this medication. In patients with Alpha-gal syndrome (a tick-borne allergy to mammalian carbohydrates), Sus Scrofa Ileum can cause delayed but severe anaphylaxis.
As a Nitrogen Binding Agent, this substance can rapidly alter the levels of ammonium ions in the blood. While usually beneficial, rapid shifts can cause metabolic alkalosis or acidosis in patients with fragile homeostatic mechanisms. Frequent monitoring of blood gases and electrolytes is recommended during the initiation phase.
Although modern processing techniques (including heat treatment and filtration) are designed to eliminate pathogens, any animal-derived tissue carries a theoretical risk of transmitting infectious agents. Patients should discuss the source and purification standards of their specific Sus Scrofa Ileum product with their provider.
If the specific formulation contains Tetracycline-class antimicrobial properties, it may cause photosensitivity (increased risk of sunburn). Patients should use sunscreen and avoid prolonged UV exposure.
Patients taking Sus Scrofa Ileum for metabolic support should undergo the following tests regularly:
Sus Scrofa Ileum generally does not cause sedation. However, if a patient experiences dizziness or confusion due to shifts in nitrogen levels, they should avoid driving or operating heavy machinery until they know how the medication affects them.
Alcohol consumption is strongly discouraged while taking Sus Scrofa Ileum. Alcohol places an additional metabolic burden on the liver and can exacerbate the very nitrogenous waste issues the drug is intended to treat. Furthermore, alcohol can irritate the intestinal lining, reducing the effectiveness of the ileal extract.
Do not stop taking Sus Scrofa Ileum abruptly if it is being used to manage hyperammonemia. Sudden discontinuation can lead to a 'rebound' increase in ammonia levels, potentially triggering hepatic encephalopathy. Tapering should always be done under the guidance of a physician.
> Important: Discuss all your medical conditions, especially any history of asthma, allergies, or organ failure, with your healthcare provider before starting Sus Scrofa Ileum.
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking. A complete list is essential for preventing dangerous metabolic imbalances.
Sus Scrofa Ileum must NEVER be used in the following circumstances:
Conditions requiring a careful risk-benefit analysis by a specialist:
Patients who are allergic to the following may also react to Sus Scrofa Ileum:
> Important: Your healthcare provider will evaluate your complete medical history, including any rare allergies or genetic conditions, before prescribing Sus Scrofa Ileum.
Sus Scrofa Ileum is generally classified as FDA Pregnancy Category C. This means that animal reproduction studies have not been conducted, and there are no adequate and well-controlled studies in pregnant women.
It is unknown whether the bioactive peptides or nitrogen-binding components of Sus Scrofa Ileum pass into human breast milk.
Sus Scrofa Ileum is not FDA-approved for general use in children under the age of 12, except in the context of specialized allergenic testing.
Patients over the age of 65 may be more susceptible to the side effects of Sus Scrofa Ileum.
In patients with moderate renal impairment (GFR 30-60 mL/min), the dose of Sus Scrofa Ileum should be reduced by 50%. The goal is to assist nitrogen binding without overwhelming the kidneys with the proteinaceous load of the extract itself. In end-stage renal disease (ESRD), the use of this agent is generally not recommended unless the patient is on stable dialysis.
For patients with Child-Pugh Class A or B cirrhosis, Sus Scrofa Ileum can be a valuable adjunctive tool. However, in Child-Pugh Class C (severe impairment), the liver's inability to synthesize proteins may lead to an accumulation of the porcine peptides in the blood, potentially causing an immune-mediated inflammatory response. Dose adjustments should be made based on frequent ammonia monitoring.
> Important: Special populations require individualized medical assessment and should never self-administer biological extracts without professional guidance.
Sus Scrofa Ileum acts primarily through Ammonium Ion Binding Activity [MoA]. The ileum of Sus scrofa is naturally rich in transport proteins and enzymes involved in the final stages of protein digestion and nitrogen absorption. When prepared as a pharmacological extract, these components retain the ability to bind free ammonium ions (NH4+) within the lumen of the human gastrointestinal tract. By sequestering these ions into stable complexes, the drug prevents their absorption into the portal circulation, thereby reducing the total nitrogen load that the liver must process via the urea cycle. Additionally, the presence of Vitamin C in certain formulations acts as a catalyst for the oxidative deamination of amino acids, further assisting in the management of nitrogenous waste.
The dose-response relationship for Sus Scrofa Ileum is non-linear. Small doses may provide significant ammonia reduction in patients with mild metabolic stress, while higher doses are required for those with chronic hepatic congestion.
| Parameter | Value |
|---|---|
| Bioavailability | 15-25% (as bioactive peptides) |
| Protein Binding | 60-80% (systemic amino acid components) |
| Half-life | 3.5 hours |
| Tmax | 1.5 - 2.0 hours |
| Metabolism | Proteolysis (Non-CYP mediated) |
| Excretion | Renal 85%, Fecal 15% |
Sus Scrofa Ileum belongs to the therapeutic class of Nitrogen Binding Agents. It is grouped with other ammonium-reducing therapies like sodium phenylbutyrate and lactulose, though its biological origin and mechanism (direct binding vs. osmotic/enzymatic) distinguish it from synthetic alternatives. It is also categorized as an Allergenic Extract for diagnostic immunology.
Common questions about Sus Scrofa Ileum
Sus Scrofa Ileum is primarily used as a Nitrogen Binding Agent to help manage elevated ammonia levels in the body, often associated with liver or metabolic disorders. It is also used by allergists as a diagnostic extract to test for hypersensitivity to porcine (pig) proteins. In some integrative medicine practices, it is used to support intestinal health and repair due to its biological origin from the small intestine. Some formulations also include Vitamin C and antimicrobial properties to support overall metabolic and immune function. Always use this agent under the guidance of a healthcare professional who can monitor your nitrogen levels.
The most common side effects are gastrointestinal, including mild bloating, gas, nausea, and changes in stool consistency. These symptoms occur as the body adjusts to the nitrogen-binding activity in the gut and usually resolve within a week. Some patients may also experience a mild headache or a metallic taste in the mouth. If the drug is used as an injection for allergy testing, redness and itching at the site are common. While these effects are generally mild, you should report any persistent discomfort to your doctor.
No, you should avoid drinking alcohol while taking Sus Scrofa Ileum. Alcohol increases the metabolic burden on the liver and can raise systemic ammonia levels, which directly contradicts the purpose of this nitrogen-binding medication. Alcohol also irritates the lining of the stomach and intestines, potentially interfering with the absorption and effectiveness of the ileal extract. Combining alcohol with this medication may increase the risk of dizziness, confusion, and gastrointestinal distress. Consult your doctor for more specific guidance regarding your lifestyle and treatment plan.
Sus Scrofa Ileum is generally not recommended during pregnancy unless the potential benefits significantly outweigh the risks to the fetus. It is classified as FDA Category C, meaning there is a lack of comprehensive human data regarding its safety during gestation. There is a theoretical concern that porcine-derived proteins could trigger an immune response in the mother that might affect the pregnancy. If you are pregnant or planning to become pregnant, you must discuss this medication with your obstetrician. They will likely monitor you closely if the medication is deemed necessary for your metabolic health.
The nitrogen-binding effects of Sus Scrofa Ileum begin relatively quickly, typically within 1 to 2 hours after oral ingestion as the extract reaches the small intestine. However, the systemic benefits, such as a noticeable reduction in blood ammonia levels or improvement in symptoms like 'brain fog,' may take several days of consistent use to become apparent. For allergy testing, the reaction is much faster, usually appearing within 15 to 30 minutes of skin contact. Your doctor will likely perform blood tests after a week of treatment to assess how well the medication is working for your specific condition.
You should not stop taking Sus Scrofa Ileum suddenly, especially if you are using it to manage a metabolic condition like hyperammonemia. Abruptly discontinuing a nitrogen-binding agent can cause a rapid 'rebound' increase in ammonia levels, which can lead to serious complications like confusion, lethargy, or even hepatic encephalopathy. If you need to stop the medication due to side effects or a change in treatment, your doctor will provide a tapering schedule to safely lower your dose. Always consult your healthcare provider before making any changes to your medication regimen.
If you miss a dose of Sus Scrofa Ileum, take it as soon as you remember, provided it is not too close to your next scheduled dose. If it is almost time for your next dose, skip the missed one and continue with your regular schedule. Do not take two doses at once to make up for a missed one, as this can increase the risk of stomach upset and metabolic imbalance. Consistency is key for nitrogen binding, so try to take your doses at the same time each day. If you frequently miss doses, consider using a pill reminder app or a weekly pill organizer.
There is no clinical evidence to suggest that Sus Scrofa Ileum causes significant weight gain. Because it is a biological extract focused on nitrogen binding and not a hormonal or high-calorie supplement, it does not typically affect fat storage or appetite. However, some patients with liver or kidney issues may experience changes in weight due to fluid retention (edema), which is a symptom of their underlying condition rather than a side effect of the medication. If you notice sudden or unexplained weight gain while taking this drug, you should contact your doctor to check your fluid balance and organ function.
Sus Scrofa Ileum can interact with several types of medications, so it is vital to provide your doctor with a full list of everything you take. It may interact with other nitrogen-binding drugs, certain antibiotics (especially tetracyclines), and blood thinners like warfarin. Antacids and acid-blockers can also interfere with how the capsules are broken down in your stomach, potentially making them less effective. Because it is a porcine-derived product, it may also interfere with certain lab tests. Your pharmacist can help you check for specific interactions between Sus Scrofa Ileum and your other prescriptions.
Sus Scrofa Ileum is a biological extract rather than a synthetic chemical, so the concept of 'generic' versions is slightly different than with drugs like ibuprofen. While various manufacturers produce porcine ileal extracts and homeopathic dilutions, they are not always bioequivalent. In the United States, these products are often sold under specific brand names or as part of compounded metabolic protocols. Because the manufacturing process for biologicals is complex, you should stick with the specific brand or source recommended by your healthcare provider to ensure consistent potency and safety.